Understanding and Communicating the Value of Quality

The webinar presents a model for evaluating quality costs and benefits in the life sciences ecosystem, emphasizing investment, performance improvement, revenue growth, stakeholder impact, and quality culture.
  • Thursday
  • October
  • 17
  • 2024
10:00 AM PDT | 01:00 PM EDT
Duration: 75 Minutes
IMG Patterson Shafer
Webinar Id: 60339
Live
Session
$119.00
Single Attendee
$249.00
Group Attendees
Recorded
Session
$159.00
Single Attendee
$359.00
Group Attendees
Combo
Live+Recorded
$249.00
Single Attendee
$549.00
Group Attendees

Overview:

A model for measuring cost of poor quality and benefit of good quality.  Understanding the impact of quality across the life sciences ecosystem.

Why you should Attend:

Quality has traditionally been considered an expense. Leading companies, however, consider quality a competitive advantage. Investing in quality not only avoids cost of poor quality but can improve performance and speed time to revenue.

The webinar will present what is considered to be a best practices model for value of quality, identifying costs as well as benefits that should be measured as part of a value of quality initiative. Understanding costs of quality and benefits of quality is critical to establishing an effective target return on investment (ROI). 

The webinar will also present best practices for measuring and communicating value of quality as well as understanding the impact of quality on stakeholders outside the organization. The impact of culture of quality will also be presented.

Areas Covered in the Session:

  • Cost of quality / value of quality financial model
  • Quality enablers - culture, measurement, leadership
  • Best practices, lessons learned

Who Will Benefit:

  • Operational and Corporate Leaders
  • Quality Leadership

Speaker Profile

Patterson Shafer has over 30 years of experience solving complex global challenges and helping clients achieve their strategic and operational objectives in the areas of quality and compliance, regulatory affairs and operations, clinical, safety and surveillance, manufacturing, supply chain, medical affairs and commercial.

Pat has extensive knowledge and experience with post-market surveillance and field actions, including recall readiness. His work in that area includes identifying technology solutions to detect quality and safety signals, reengineered pharmacovigilance, complaint, CAPA and field action (recall) processes, and redesigned medical review organizations to advance compliance, safety, and operational efficiency. He has written recall best practices playbooks, published articles, and presented at multiple conferences on the subject, in addition to overseeing multiple recalls for medical device companies.